GRANT PICKERING - 27 Dec 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role: Chief Executive Officer, Director
Signature: /s/ Ron Metzger, Attorney-in-Fact
Issuer symbol: PCVX
Transactions as of: 27 Dec 2021
Net transactions value: +$92,995
Form type: 4
Filing time: 28 Dec 2021, 15:14:32 UTC
Previous filing: 23 Nov 2021
Next filing: 31 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCVX	Common Stock	Options Exercise	$90,153	+50,365	+8.7%	$1.79	630,619	27 Dec 2021	Direct
transaction	PCVX	Common Stock	Options Exercise	$2,842	+1,400	+0.22%	$2.03	632,019	27 Dec 2021	Direct
holding	PCVX	Common Stock						355,660	27 Dec 2021	By Children's Trusts

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCVX	Stock Option (right to buy)	Options Exercise	$0	-50,365	-15%	$0.000000	278,450	27 Dec 2021	Common Stock	50,365	$1.79	Direct	F1
transaction	PCVX	Stock Option (right to buy)	Options Exercise	$0	-1,400	-0.24%	$0.000000	594,332	27 Dec 2021	Common Stock	1,400	$2.03	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option are fully vested and exercisable.
F2	1/4 of the shares subject to the option vested on July 24, 2019, and 1/48 of the shares vest monthly thereafter.